Expanding the anti-TB arsenal

A new tuberculosis drug target reveals an additional antimicrobial resistance mechanism Tuberculosis (TB) is the leading cause of mortality from an infectious agent globally, with 1.6 million deaths and more than 10 million new cases annually ( 1 ). Since the 1950s, long-term combination chemotherap...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Science (American Association for the Advancement of Science) 2019-02, Vol.363 (6426), p.457-458
Hauptverfasser:	Mizrahi, Valerie, Warner, Digby F
Format:	Artikel
Sprache:	eng
Schlagworte:	Antimicrobial resistance Antitubercular Agents Biochemical Phenomena Chemotherapy Coenzymes Diagnostic Tests, Routine Drug development Drug resistance Erosion resistance Fatalities Mycobacterium tuberculosis Tuberculosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!